Join
Live feed
·
INSIDERFilingvia Quantisnow
Aktis Oncology Inc. logo

Geiss Arthur bought $25,000 worth of shares (50,000 units at $0.50), increasing direct ownership by 14% to 415,924 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AKTS· Aktis Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKTS (Aktis Oncology Inc.) and more on Quantisnow.